Aptarion Biotech AG
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia. (NCT05962606) | Aptarion Biotech AG | 2024-02-02 |
| Ascending Multiple Intravenous Doses of AON-D21 in Healthy Male Subjects. (NCT05343819) | Aptarion Biotech AG | 2022-04-12 |
| First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects (NCT05018403) | Aptarion Biotech AG | 2021-08-03 |
Track Aptarion Biotech AG automatically
Every clearance here is in the API, with alerts when new ones post.